GlassScriptPhysician profile
Madeline K Giacalone
NPI 1831539667
$6,866.76
in general payments reported to CMS, 2019-2025
41 companies · $914 in 2025
The $914 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,767 · 2020: $175 · 2021: $785 · 2022: $1,200 · 2023: $1,135 · 2024: $890 · 2025: $914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,939.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,202.83 | 2019 | |
| Abbvie INC. | $1,056.68 | 2019-2025 | |
| Evofem Biosciences, INC. | $657.37 | 2021-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $461.42 | 2021-2025 | |
| Amgen INC. | $359.01 | 2020-2023 | Evenity, Prolia |
| Sage Therapeutics, LLC | $269.98 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $238.30 | 2019-2025 | Third Wave, Thinprep 2000 Processor, Aptima |
| Pfizer INC. | $237.28 | 2019-2025 | |
| Astellas Pharma US INC | $228.12 | 2022-2025 | Veozah |
| Allergan, INC. | $210.12 | 2019-2020 | |
| Organon LLC | $203.53 | 2022-2025 | Nexplanon |
| Novo Nordisk INC | $161.72 | 2022-2025 | Wegovy |
| Sumitomo Pharma America, INC. | $158.31 | 2023-2025 | Myfembree |
| Agile Therapeutics, INC. | $148.36 | 2021-2024 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $146.28 | 2019-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $116.20 | 2022-2025 | Slynd |
| Millicent US INC | $97.39 | 2024-2025 | Intrarosa, Femlyv |
| Therapeuticsmd, INC. | $96.39 | 2019-2022 | |
| Meditrina | $85.95 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $78.30 | 2022-2023 | Quviviq |
| Mission Pharmacal Company | $61.76 | 2019-2020 | |
| Lupin INC. | $57.09 | 2019-2020 | |
| Avion Pharmaceuticals | $52.00 | 2022-2023 | Balcoltra |
| Myovant Sciences INC. | $51.44 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $49.91 | 2019 | |
| Exact Sciences Corporation | $44.39 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $43.30 | 2019-2025 | Gardasil 9, Gardasil |
| Ethicon US, LLC | $39.59 | 2024 | Dermabond |
| Radius Health, INC. | $38.47 | 2022-2023 | Tymlos |
| Mylan Pharmaceuticals INC. | $24.83 | 2022 | |
| Intuitive Surgical, INC. | $22.88 | 2022 | |
| Covidien LP | $22.60 | 2019 | |
| Gynesonics, INC. | $20.75 | 2022 | |
| Optumhealth Care Solutions, LLC | $19.26 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Shield Therapeutics INC | $17.81 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.74 | 2022 | |
| Supernus Pharmaceuticals, INC. | $17.49 | 2025 | Qelbree |
| Coopersurgical, INC. | $16.37 | 2023 | Wallach Cryosurgical Equipment |
| Duchesnay USA Incorporated | $12.20 | 2019 | |
| Scynexis, INC. | $11.74 | 2022 | |
| Currax Pharmaceuticals LLC | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madeline Giacalone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.